EVFM (OTC)
EVOFEM BIOSCIENCE INC
$0.007900
-0.000900 (-10.23%)
Prev close: $0.008800
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Saundra L. Pelletier
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.01M
- Employees
- 37
- P/E (TTM)
- —
- P/B (TTM)
- -0.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.03 | $0.00 | +0.0000 | +0.00% |
|
Dec 2023 (Q4)
|
$-0.44 | $-0.62 | +0.1822 | +29.28% |
|
Sep 2023 (Q3)
|
$0.10 | $-0.06 | +0.1612 | +263.40% |
|
Mar 2022 (Q4)
|
$-38.75 | $-26.78 | -11.9750 | -44.72% |
Financial Statements
| Revenues | $20.24M |
| Benefits Costs and Expenses | $26.27M |
| Cost Of Revenue | $4.66M |
| Costs And Expenses | $21.76M |
| Gross Profit | $15.58M |
| Nonoperating Income/Loss | -$4.51M |
| Operating Expenses | $17.10M |
| Operating Income/Loss | -$1.52M |
| Income/Loss From Continuing Operations After Tax | -$6.04M |
| Income/Loss From Continuing Operations Before Tax | -$6.03M |
| Interest Expense, Operating | $2.40M |
| Net Income/Loss | -$6.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $133.00K |
| Preferred Stock Dividends And Other Adjustments | $133.00K |
| Basic Earnings Per Share | -$0.05 |
| Diluted Earnings Per Share | -$0.05 |
| Basic Average Shares | 375,939,282 |
| Diluted Average Shares | 6,674,027,922 |
| Assets | $7.44M |
| Current Assets | $6.06M |
| Inventory | $1.89M |
| Other Current Assets | $4.17M |
| Noncurrent Assets | $1.39M |
| Fixed Assets | $416.00K |
| Other Non-current Assets | $970.00K |
| Liabilities | $80.15M |
| Current Liabilities | $78.75M |
| Accounts Payable | $12.00M |
| Wages | $1.50M |
| Other Current Liabilities | $65.25M |
| Noncurrent Liabilities | $1.40M |
| Equity | -$77.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$77.63M |
| Temporary Equity | $4.92M |
| Temporary Equity Attributable To Parent | $4.92M |
| Liabilities And Equity | $7.44M |
| Net Cash Flow From Operating Activities | -$251.00K |
| Net Cash Flow From Operating Activities, Continuing | -$251.00K |
| Net Cash Flow From Investing Activities | -$7.00K |
| Net Cash Flow From Investing Activities, Continuing | -$7.00K |
| Net Cash Flow From Financing Activities | $1.53M |
| Net Cash Flow From Financing Activities, Continuing | $1.53M |
| Net Cash Flow | $1.27M |
| Net Cash Flow, Continuing | $1.27M |
| Comprehensive Income/Loss | -$10.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.69M |
| Other Comprehensive Income/Loss | -$8.33M |